Ring chromosome 6 syndrome

Ring chromosome 6 syndrome (also known as ring 6, r(6) syndrome) is a rare chromosomal disorder in which the two ends of chromosome 6 fuse to form a ring structure, typically with loss of genetic material from one or both ends of the chromosome. This structural rearrangement usually occurs as a de novo (new) event and is not inherited from a parent. The clinical presentation is highly variable depending on the amount and location of deleted genetic material, as well as the degree of ring chromosome instability, which can lead to mosaicism with monosomic or other aneuploid cell lines. Key clinical features commonly reported in individuals with ring chromosome 6 include intrauterine growth restriction, short stature, intellectual disability of variable severity, microcephaly, and characteristic facial dysmorphisms such as a flat nasal bridge, epicanthal folds, low-set ears, and micrognathia. Additional findings may include limb anomalies, seizures, cardiac defects, and eye abnormalities including microphthalmia. Hypotonia and feeding difficulties are frequently observed in infancy. Some patients may also exhibit hydrocephalus or craniosynostosis. The phenotypic spectrum ranges from mild to severe depending on the extent of chromosomal material lost. There is no specific cure or targeted therapy for ring chromosome 6 syndrome. Management is supportive and symptomatic, tailored to the individual's clinical manifestations. This may include early intervention programs, speech and physical therapy, management of seizures with antiepileptic medications, surgical correction of cardiac or skeletal anomalies, and regular developmental and ophthalmologic assessments. Genetic counseling is recommended for affected families, although recurrence risk is generally low given the typically sporadic nature of the condition.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Ring chromosome 6 syndrome